Trials / Terminated
TerminatedNCT00717522
Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma
A Phase 2, Multicenter, Open-label, Single Arm, Two-stage Study to Evaluate the Efficacy and Safety of CC-4047 (Pomalidomide) in Patients With Advanced Soft Tissue Sarcomas Who Have Relapsed or Are Refractory to Systemic Anticancer Therapy
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine the safety and efficacy of single agent CC-4047 (pomalidomide) in patients with advanced soft tissue sarcomas who have relapsed or are refractory to prior anticancer therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pomalidomide |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2009-01-01
- Completion
- 2009-01-01
- First posted
- 2008-07-17
- Last updated
- 2019-11-19
- Results posted
- 2013-04-16
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00717522. Inclusion in this directory is not an endorsement.